Raydiant Oximetry Raises $5M in Series A2 Financing
- Fogarty Innovation, a nonprofit educational incubator for medical technology companies raised a $5m Series A2 financing
- The round was led by Avestria Ventures, with participation from KOFA Healthcare, V-Capital, Band of Angels, FemHealth Ventures, RHIA Ventures and SteelSky Ventures
- RaydiantOximetry is a San Ramon, CA USA-based clinical-stage medical device company focused on improving women’s and neonatal health
- Its innovation is LUMERAHTM, the non-invasive fetal oximeter designed to detect fetal distress during labor and delivery
- It is an investigational medical device that is not currently approved for commercial sale
- The company intends to use the funds to complete a clinical study at the University of Texas Medical Branch (UTMB) in Galveston, Texas
